{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:09:28Z","timestamp":1778724568923,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M743976"],"award-info":[{"award-number":["2023M743976"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82405101"],"award-info":[{"award-number":["82405101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"High-level Key Discipline Construction project of Traditional Chinese Medicine","award":["ZYYZDXK-2023259"],"award-info":[{"award-number":["ZYYZDXK-2023259"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09784-0","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:36:11Z","timestamp":1778722571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Crosstalk between the monocytes and coagulation factor V\u2161a aggravates the inflammation in patients with CAD"],"prefix":"10.1007","volume":"74","author":[{"given":"Baofu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengyao","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"9784_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","volume":"42","author":"PR Lawler","year":"2021","unstructured":"Lawler PR, Bhatt DL, Godoy LC, L\u00fcscher TF, Bonow RO, et al. Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J. 2021;42:113\u201331. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa099.","journal-title":"Eur Heart J"},{"key":"9784_CR2","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019;381:2497\u2013505. https:\/\/doi.org\/10.1056\/NEJMoa1912388.","journal-title":"N Engl J Med"},{"key":"9784_CR3","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet A, Mosterd A, Eikelboom JW, Schut A, et al. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020;383:1838\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2021372.","journal-title":"N Engl J Med"},{"key":"9784_CR4","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","volume":"41","author":"N Bouabdallaoui","year":"2020","unstructured":"Bouabdallaoui N, Tardif JC, Waters DD, Pinto FJ, Maggioni AP, et al. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J. 2020;41:4092\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa659.","journal-title":"Eur Heart J"},{"key":"9784_CR5","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","volume":"142","author":"DC Tong","year":"2020","unstructured":"Tong DC, Quinn S, Nasis A, Hiew C, Roberts-Thomson P, et al. Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial. Circulation. 2020;142:1890\u2013900. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050771.","journal-title":"Circulation"},{"key":"9784_CR6","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.120.050560","volume":"142","author":"T Opstal","year":"2020","unstructured":"Opstal T, Hoogeveen RM, Fiolet A, Silvis M, The S, et al. Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy. Circulation. 2020;142:1996\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050560.","journal-title":"Circulation"},{"key":"9784_CR7","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","volume":"77","author":"K Broch","year":"2021","unstructured":"Broch K, Anstensrud AK, Woxholt S, Sharma K, T\u00f8llefsen IM, et al. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2021;77:1845\u201355. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.049.","journal-title":"J Am Coll Cardiol"},{"key":"9784_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","volume":"380","author":"PM Ridker","year":"2019","unstructured":"Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, et al. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events. N Engl J Med. 2019;380:752\u201362. https:\/\/doi.org\/10.1056\/NEJMoa1809798.","journal-title":"N Engl J Med"},{"key":"9784_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1042\/CS20170009","volume":"131","author":"CN Fran\u00e7a","year":"2017","unstructured":"Fran\u00e7a CN, Izar M, Hort\u00eancio M, do Amaral JB, Ferreira C, et al. Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease. Clin Sci (Lond). 2017;131:1215\u201324. https:\/\/doi.org\/10.1042\/CS20170009.","journal-title":"Clin Sci (Lond)"},{"key":"9784_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-017-0577-8","volume":"16","author":"N Yoshida","year":"2017","unstructured":"Yoshida N, Yamamoto H, Shinke T, Otake H, Kuroda M, et al. Impact of CD14(++)CD16(+) monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study. Cardiovasc Diabetol. 2017;16:96. https:\/\/doi.org\/10.1186\/s12933-017-0577-8.","journal-title":"Cardiovasc Diabetol"},{"key":"9784_CR11","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jacc.2012.07.019","volume":"60","author":"KS Rogacev","year":"2012","unstructured":"Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, et al. CD14\u2009+\u2009+\u2009CD16\u2009+\u2009monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol. 2012;60:1512\u201320. https:\/\/doi.org\/10.1016\/j.jacc.2012.07.019.","journal-title":"J Am Coll Cardiol"},{"key":"9784_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12931-018-0891-z","volume":"19","author":"AC Trombetta","year":"2018","unstructured":"Trombetta AC, Soldano S, Contini P, Tomatis V, Ruaro B, et al. A circulating cell population showing both M1 and M2 monocyte\/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. Respir Res. 2018;19:186. https:\/\/doi.org\/10.1186\/s12931-018-0891-z.","journal-title":"Respir Res"},{"key":"9784_CR13","doi-asserted-by":"publisher","first-page":"960398","DOI":"10.3389\/fcvm.2023.960398","volume":"10","author":"CC Rolling","year":"2023","unstructured":"Rolling CC, Barrett TJ, Berger JS. Platelet-monocyte aggregates: molecular mediators of thromboinflammation. Front Cardiovasc Med. 2023;10:960398. https:\/\/doi.org\/10.3389\/fcvm.2023.960398.","journal-title":"Front Cardiovasc Med"},{"key":"9784_CR14","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.323662","volume":"134","author":"C Li","year":"2024","unstructured":"Li C, Ture SK, Nieves-Lopez B, Blick-Nitko SK, Maurya P, et al. Thrombocytopenia Independently Leads to Changes in Monocyte Immune Function. Circ Res. 2024;134:970\u201386. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.323662.","journal-title":"Circ Res"},{"key":"9784_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1055\/s-0042-1758655","volume":"123","author":"CC Rolling","year":"2023","unstructured":"Rolling CC, Sowa MA, Wang TT, Cornwell M, Myndzar K, et al. P2Y12 Inhibition Suppresses Proinflammatory Platelet-Monocyte Interactions. Thromb Haemost. 2023;123:231\u201344. https:\/\/doi.org\/10.1055\/s-0042-1758655.","journal-title":"Thromb Haemost"},{"key":"9784_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122943","author":"ZT Hilt","year":"2019","unstructured":"Hilt ZT, Pariser DN, Ture SK, Mohan A, Quijada P, et al. Platelet-derived \u03b22M regulates monocyte inflammatory responses. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.122943. 4.","journal-title":"JCI Insight"},{"key":"9784_CR17","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/s44321-024-00093-3","volume":"16","author":"I Hawwari","year":"2024","unstructured":"Hawwari I, Rossnagel L, Rosero N, Maasewerd S, Vasconcelos MB, et al. Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes. EMBO Mol Med. 2024;16:1901\u201329. https:\/\/doi.org\/10.1038\/s44321-024-00093-3.","journal-title":"EMBO Mol Med"},{"key":"9784_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","volume":"38","author":"SP Grover","year":"2018","unstructured":"Grover SP, Mackman N. Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis. Arterioscler Thromb Vasc Biol. 2018;38:709\u201325. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309846.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9784_CR19","doi-asserted-by":"publisher","first-page":"17459","DOI":"10.1038\/s41598-021-95710-3","volume":"11","author":"PM Siegel","year":"2021","unstructured":"Siegel PM, Sander L, Fricke A, Stamm J, Wang X, et al. P(2)Y(12) receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells. Sci Rep. 2021;11:17459. https:\/\/doi.org\/10.1038\/s41598-021-95710-3.","journal-title":"Sci Rep"},{"key":"9784_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/CIRCRESAHA.119.316062","volume":"129","author":"C Kassiteridi","year":"2021","unstructured":"Kassiteridi C, Cole JE, Griseri T, Falck-Hansen M, Goddard ME, et al. CD200 Limits Monopoiesis and Monocyte Recruitment in Atherosclerosis. Circ Res. 2021;129:280\u201395. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316062.","journal-title":"Circ Res"},{"key":"9784_CR21","doi-asserted-by":"publisher","first-page":"106328","DOI":"10.1016\/j.phrs.2022.106328","volume":"182","author":"H Chai","year":"2022","unstructured":"Chai H, Qu H, He S, Song L, Yang Y, et al. Zedoarondiol inhibits atherosclerosis by regulating monocyte migration and adhesion via CXCL12\/CXCR4 pathway. Pharmacol Res. 2022;182:106328. https:\/\/doi.org\/10.1016\/j.phrs.2022.106328.","journal-title":"Pharmacol Res"},{"key":"9784_CR22","doi-asserted-by":"publisher","first-page":"e12883","DOI":"10.1111\/sji.12883","volume":"92","author":"A O\u017ca\u0144ska","year":"2020","unstructured":"O\u017ca\u0144ska A, Szymczak D, Rybka J. Pattern of human monocyte subpopulations in health and disease. Scand J Immunol. 2020;92:e12883. https:\/\/doi.org\/10.1111\/sji.12883.","journal-title":"Scand J Immunol"},{"key":"9784_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.vph.2018.12.002","volume":"113","author":"AK Vlacil","year":"2019","unstructured":"Vlacil AK, Schuett J, Schieffer B, Grote K. Variety matters: Diverse functions of monocyte subtypes in vascular inflammation and atherogenesis. Vascul Pharmacol. 2019;113:9\u201319. https:\/\/doi.org\/10.1016\/j.vph.2018.12.002.","journal-title":"Vascul Pharmacol"},{"key":"9784_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.atherosclerosis.2014.10.106","volume":"237","author":"GP Fadini","year":"2014","unstructured":"Fadini GP, Simoni F, Cappellari R, Vitturi N, Galasso S, et al. Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. Atherosclerosis. 2014;237:805\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.10.106.","journal-title":"Atherosclerosis"},{"key":"9784_CR25","doi-asserted-by":"publisher","first-page":"5270657","DOI":"10.1155\/2018\/5270657","volume":"2018","author":"J Hou","year":"2018","unstructured":"Hou J, Zhang M, Ding Y, Wang X, Li T, et al. Circulating CD14(+)CD163(+)CD206(+) M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy. Mediators Inflamm. 2018;2018:5270657. https:\/\/doi.org\/10.1155\/2018\/5270657.","journal-title":"Mediators Inflamm"},{"key":"9784_CR26","doi-asserted-by":"publisher","first-page":"e23984","DOI":"10.1002\/jcla.23984","volume":"35","author":"O Babania","year":"2021","unstructured":"Babania O, Mohammadi S, Yaghoubi E, Sohrabi A, Sadat Seyedhosseini F, et al. The expansion of CD14\u2009+\u2009CD163+ subpopulation of monocytes and myeloid cells-associated cytokine imbalance; candidate diagnostic biomarkers for celiac disease (CD). J Clin Lab Anal. 2021;35:e23984. https:\/\/doi.org\/10.1002\/jcla.23984.","journal-title":"J Clin Lab Anal"},{"key":"9784_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.intimp.2018.02.018","volume":"57","author":"M Zhang","year":"2018","unstructured":"Zhang M, Ding L, Wang X, Hou J, Li M, et al. Circulating CD14(+)CD163(+)CD115(+) M2 monocytes are associated with the severity of new onset severe acute pancreatitis in Chinese patients. Int Immunopharmacol. 2018;57:181\u20139. https:\/\/doi.org\/10.1016\/j.intimp.2018.02.018.","journal-title":"Int Immunopharmacol"},{"key":"9784_CR28","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3748\/wjg.v23.i8.1477","volume":"23","author":"ML Zhang","year":"2017","unstructured":"Zhang ML, Jiang YF, Wang XR, Ding LL, Wang HJ, et al. Different phenotypes of monocytes in patients with new-onset mild acute pancreatitis. World J Gastroenterol. 2017;23:1477\u201388. https:\/\/doi.org\/10.3748\/wjg.v23.i8.1477.","journal-title":"World J Gastroenterol"},{"key":"9784_CR29","doi-asserted-by":"publisher","first-page":"c105","DOI":"10.1159\/000085289","volume":"100","author":"JA Sj\u00f8land","year":"2005","unstructured":"Sj\u00f8land JA, Pedersen RS, Jespersen J, Gram J. Intraperitoneal heparin ameliorates the systemic inflammatory response in PD patients. Nephron Clin Pract. 2005;100:c105\u201310. https:\/\/doi.org\/10.1159\/000085289.","journal-title":"Nephron Clin Pract"},{"key":"9784_CR30","doi-asserted-by":"publisher","first-page":"109330","DOI":"10.1016\/j.mehy.2019.109330","volume":"132","author":"W Shiqing","year":"2019","unstructured":"Shiqing W, Shengzhong M, Cheng Z, Guangqing C, Chunzheng G. Efficacy of low molecular weight heparin in spinal trauma patients after part concentrated screw surgery and its influence on blood parameters and the incidence of deep venous thrombosis. Med Hypotheses. 2019;132:109330. https:\/\/doi.org\/10.1016\/j.mehy.2019.109330.","journal-title":"Med Hypotheses"},{"key":"9784_CR31","doi-asserted-by":"publisher","first-page":"101603","DOI":"10.1016\/j.trim.2022.101603","volume":"73","author":"ZF Chen","year":"2022","unstructured":"Chen ZF, Gui CM, Xie ZH. The effects of continuous renal replacement therapy with different anticoagulation methods on the expression of cytokines in severe acute pancreatitis. Transpl Immunol. 2022;73:101603. https:\/\/doi.org\/10.1016\/j.trim.2022.101603.","journal-title":"Transpl Immunol"},{"key":"9784_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/15412555.2013.831062","volume":"11","author":"Y Qian","year":"2014","unstructured":"Qian Y, Xie H, Tian R, Yu K, Wang R. Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. COPD. 2014;11:171\u20136. https:\/\/doi.org\/10.3109\/15412555.2013.831062.","journal-title":"COPD"},{"key":"9784_CR33","doi-asserted-by":"publisher","first-page":"e0316474","DOI":"10.1371\/journal.pone.0316474","volume":"20","author":"K Maekawa","year":"2025","unstructured":"Maekawa K, Nakamura E, Saito Y, Matsuura Y, Gi T, et al. Inflammatory stimuli and hypoxia on atherosclerotic plaque thrombogenicity: Linking macrophage tissue factor and glycolysis. PLoS ONE. 2025;20:e0316474. https:\/\/doi.org\/10.1371\/journal.pone.0316474.","journal-title":"PLoS ONE"},{"key":"9784_CR34","doi-asserted-by":"publisher","unstructured":"Starikova EA, Mammedova JT, Rubinstein AA, Sokolov AV, Kudryavtsev IV. Activation of the coagulation cascade as a universal danger sign. Curr Issues Mol Biol. 2025;47. https:\/\/doi.org\/10.3390\/cimb47020108.","DOI":"10.3390\/cimb47020108"},{"key":"9784_CR35","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/CIRCRESAHA.123.324114","volume":"135","author":"V Garlapati","year":"2024","unstructured":"Garlapati V, Luo Q, Posma J, Aluia M, Nguyen TS, et al. Macrophage-Expressed Coagulation Factor VII Promotes Adverse Cardiac Remodeling. Circ Res. 2024;135:841\u201355. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.324114.","journal-title":"Circ Res"},{"key":"9784_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1152\/physrev.00044.2021","volume":"103","author":"CJ Peach","year":"2023","unstructured":"Peach CJ, Edgington-Mitchell LE, Bunnett NW, Schmidt BL. Protease-activated receptors in health and disease. Physiol Rev. 2023;103:717\u201385. https:\/\/doi.org\/10.1152\/physrev.00044.2021.","journal-title":"Physiol Rev"},{"key":"9784_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00281-011-0289-1","volume":"34","author":"AS Rothmeier","year":"2012","unstructured":"Rothmeier AS, Ruf W. Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol. 2012;34:133\u201349. https:\/\/doi.org\/10.1007\/s00281-011-0289-1.","journal-title":"Semin Immunopathol"},{"key":"9784_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/CS20130043","volume":"126","author":"M Satoh","year":"2014","unstructured":"Satoh M, Tabuchi T, Itoh T, Nakamura M. NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin. Clin Sci (Lond). 2014;126:233\u201341. https:\/\/doi.org\/10.1042\/CS20130043.","journal-title":"Clin Sci (Lond)"},{"key":"9784_CR39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.mayocp.2022.11.017","volume":"98","author":"MH Strauss","year":"2023","unstructured":"Strauss MH, Hall AS, Narkiewicz K. ACEI, ARB - Each Unique, RAAS Inhibitors: The Importance of Impact on Inflammation. Mayo Clin Proc. 2023;98:350\u20131. https:\/\/doi.org\/10.1016\/j.mayocp.2022.11.017.","journal-title":"Mayo Clin Proc"},{"key":"9784_CR40","doi-asserted-by":"publisher","unstructured":"Siniscalchi C, Basaglia M, Riva M, Meschi M, Meschi T, et al. Statins effects on blood clotting: a review. Cells. 2023;12. https:\/\/doi.org\/10.3390\/cells12232719.","DOI":"10.3390\/cells12232719"},{"key":"9784_CR41","doi-asserted-by":"publisher","unstructured":"Owens AP 3rd, Byrnes JR, Mackman N. Hyperlipidemia, tissue factor, coagulation, and simvastatin. Trends Cardiovasc Med. 2014;24:95-8. https:\/\/doi.org\/10.1016\/j.tcm.2013.07.003.","DOI":"10.1016\/j.tcm.2013.07.003"},{"key":"9784_CR42","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood.V89.3.767","volume":"89","author":"H Philippou","year":"1997","unstructured":"Philippou H, Adami A, Amersey RA, Stubbs PJ, Lane DA. A novel specific immunoassay for plasma two-chain factor VIIa: investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes. Blood. 1997;89:767\u201375.","journal-title":"Blood"},{"key":"9784_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/01.cir.96.1.19","volume":"96","author":"S Kapiotis","year":"1997","unstructured":"Kapiotis S, Jilma B, Quehenberger P, Ruzicka K, Handler S, Speiser W. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1\u2009+\u20092, and plasmin-plasmin inhibitor complex. Circulation. 1997;96:19\u201321. https:\/\/doi.org\/10.1161\/01.cir.96.1.19.","journal-title":"Circulation"},{"key":"9784_CR44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1080\/15384047.2018.1529123","volume":"20","author":"HK Chen","year":"2019","unstructured":"Chen HK, Wang X, Wan YL, Tang JQ. Crosstalk between TF\/FVIIa and EGFR signaling in colorectal cancer cells. Cancer Biol Ther. 2019;20:454\u201360. https:\/\/doi.org\/10.1080\/15384047.2018.1529123.","journal-title":"Cancer Biol Ther"},{"key":"9784_CR45","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1161\/ATVBAHA.120.314244","volume":"40","author":"V Kondreddy","year":"2020","unstructured":"Kondreddy V, Pendurthi UR, Xu X, Griffin JH, Rao L. FVIIa (Factor VIIa) Induces Biased Cytoprotective Signaling in Mice Through the Cleavage of PAR (Protease-Activated Receptor)-1 at Canonical Arg41 (Arginine41) Site. Arterioscler Thromb Vasc Biol. 2020;40:1275\u201388. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314244.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9784_CR46","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1182\/blood.2023021149","volume":"143","author":"H Zelaya","year":"2024","unstructured":"Zelaya H, Grunz K, Nguyen TS, Habibi A, Witzler C, et al. Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling. Blood. 2024;143:845\u201357. https:\/\/doi.org\/10.1182\/blood.2023021149.","journal-title":"Blood"},{"key":"9784_CR47","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00417-013-2335-2","volume":"251","author":"J Bastiaans","year":"2013","unstructured":"Bastiaans J, van Meurs JC, van Holten-Neelen C, Nijenhuis MS, Kolijn-Couwenberg MJ, et al. Factor Xa and thrombin stimulate proinflammatory and profibrotic mediator production by retinal pigment epithelial cells: a role in vitreoretinal disorders. Graefes Arch Clin Exp Ophthalmol. 2013;251:1723\u201333. https:\/\/doi.org\/10.1007\/s00417-013-2335-2.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9784_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbi.2023.11.035","volume":"116","author":"B He","year":"2024","unstructured":"He B, Niu L, Li S, Li H, Hou Y, et al. Sustainable inflammatory activation following spinal cord injury is driven by thrombin-mediated dynamic expression of astrocytic chemokines. Brain Behav Immun. 2024;116:85\u2013100. https:\/\/doi.org\/10.1016\/j.bbi.2023.11.035.","journal-title":"Brain Behav Immun"},{"key":"9784_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.molimm.2021.11.012","volume":"141","author":"X Fang","year":"2022","unstructured":"Fang X, Li M, Zhang W, Li J, Zhu T. Thrombin induces pro-inflammatory and anti-inflammatory cytokines secretion from human mast cell line (HMC-1) via protease-activated receptors. Mol Immunol. 2022;141:60\u20139. https:\/\/doi.org\/10.1016\/j.molimm.2021.11.012.","journal-title":"Mol Immunol"},{"key":"9784_CR50","first-page":"2326","volume":"7","author":"P Zuo","year":"2015","unstructured":"Zuo P, Zuo Z, Wang X, Chen L, Zheng Y, et al. Factor Xa induces pro-inflammatory cytokine expression in RAW 264.7 macrophages via protease-activated receptor-2 activation. Am J Transl Res. 2015;7:2326\u201334.","journal-title":"Am J Transl Res"},{"key":"9784_CR51","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1042\/bst0311191","volume":"31","author":"GS Cottrell","year":"2003","unstructured":"Cottrell GS, Amadesi S, Schmidlin F, Bunnett N. Protease-activated receptor 2: activation, signalling and function. Biochem Soc Trans. 2003;31:1191\u20137. https:\/\/doi.org\/10.1042\/bst0311191.","journal-title":"Biochem Soc Trans"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09784-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09784-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09784-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:36:14Z","timestamp":1778722574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09784-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9784"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09784-0","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the ethics committee of Dongzhimen Hospital of Beijing University of Chinese Medicine (2022DZMEC-198-02). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}